Does the combination LPL rs328 C/C, GCKR rs1260326 C/T, and PPARG rs1801282 C/C increase susceptibility to insulin resistance?

Mechanistic explanations

• Impaired Triglyceride Clearance: The LPL rs328 C/C genotype represents the common, wild-type allele lacking the protective Ser447Ter (G) variant. The absent G allele means individuals miss out on enhanced lipoprotein lipase activity, which otherwise accelerates the clearance of triglyceride-rich lipoproteins and protects against hyperinsulinemia.
• Upregulated Hepatic Lipogenesis: The GCKR rs1260326 T allele impairs glucokinase regulatory protein (GCKR) inhibition, leading to hyperactive hepatic glucokinase. This shifts hepatic glucose metabolism toward glycolytic flux, feeding directly into de novo lipogenesis and generating excess very-low-density lipoprotein (VLDL) particles and elevated fasting triglycerides.
• Reduced Adipose Insulin Sensitivity: The PPARG rs1801282 C/C (Pro/Pro) genotype lacks the protective Ala12 (G) allele. Without this variant, individuals lack the enhanced insulin-sensitizing and anti-inflammatory properties of PPAR-gamma, which are key for safe adipose tissue storage.

Clinical implications

• Lipotoxicity and Insulin Resistance: Elevated circulating triglycerides and elevated hepatic lipid synthesis from the GCKR and LPL genotypes combine to promote ectopic fat deposition in liver and muscle tissue. This accumulation of lipid intermediates (such as diacylglycerols) impairs downstream insulin receptor substrate (IRS) signaling.
• Context-Dependent Susceptibility: While the GCKR T allele is paradoxically associated with lower fasting insulin in some lean cohorts, high nutrient loads override this effect. Under metabolic stress, the accumulation of hepatic fat heavily drives insulin resistance, exacerbated by the lack of protective PPARG and LPL variants.

Bottom line

• The combination of LPL rs328 C/C, GCKR rs1260326 C/T, and PPARG rs1801282 C/C lacks key metabolic protective alleles. This combination promotes elevated triglycerides, enhanced hepatic lipogenesis, and reduced peripheral insulin sensitivity, collectively increasing susceptibility to insulin resistance under metabolic challenge.